137 related articles for article (PubMed ID: 37243318)
21. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
22. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
George RE; Variend S; Cullinane C; Cotterill SJ; McGuckin AG; Ellershaw C; Lunec J; Pearson AD;
Med Pediatr Oncol; 2001 Jan; 36(1):169-76. PubMed ID: 11464876
[TBL] [Abstract][Full Text] [Related]
23. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
[TBL] [Abstract][Full Text] [Related]
24. [Study on MYCN gene amplification and CD44 expression in neuroblastoma].
Hu HL; He LJ
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):332-6. PubMed ID: 15363318
[TBL] [Abstract][Full Text] [Related]
25. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
Umehara S; Nakagawa A; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Shimada H
Cancer; 2000 Sep; 89(5):1150-61. PubMed ID: 10964346
[TBL] [Abstract][Full Text] [Related]
26. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
Monclair T; Brodeur GM; Ambros PF; Brisse HJ; Cecchetto G; Holmes K; Kaneko M; London WB; Matthay KK; Nuchtern JG; von Schweinitz D; Simon T; Cohn SL; Pearson AD;
J Clin Oncol; 2009 Jan; 27(2):298-303. PubMed ID: 19047290
[TBL] [Abstract][Full Text] [Related]
27. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
Peuchmaur M; d'Amore ES; Joshi VV; Hata J; Roald B; Dehner LP; Gerbing RB; Stram DO; Lukens JN; Matthay KK; Shimada H
Cancer; 2003 Nov; 98(10):2274-81. PubMed ID: 14601099
[TBL] [Abstract][Full Text] [Related]
28. Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.
Bagatell R; Beck-Popovic M; London WB; Zhang Y; Pearson AD; Matthay KK; Monclair T; Ambros PF; Cohn SL;
J Clin Oncol; 2009 Jan; 27(3):365-70. PubMed ID: 19047282
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and management of ganglioneuroma and ganglioneuroblastoma-intermixed in children and adolescents.
Alexander N; Sullivan K; Shaikh F; Irwin MS
Pediatr Blood Cancer; 2018 May; 65(5):e26964. PubMed ID: 29369484
[TBL] [Abstract][Full Text] [Related]
30. The clinical management and outcomes of cervical neuroblastic tumors.
Jackson JR; Tran HC; Stein JE; Shimada H; Patel AM; Marachelian A; Kim ES
J Surg Res; 2016 Jul; 204(1):109-13. PubMed ID: 27451875
[TBL] [Abstract][Full Text] [Related]
31. Extra-adrenal peripheral neuroblastic tumors: A clinicopathological study of 18 cases.
Shankaralingappa S; Patra S; Gami A; Trivedi P; Chalaliya AK
Indian J Pathol Microbiol; 2023; 66(2):278-285. PubMed ID: 37077068
[TBL] [Abstract][Full Text] [Related]
32. Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma.
Temple WC; Vo KT; Matthay KK; Balliu B; Coleman C; Michlitsch J; Phelps A; Behr S; Zapala MA
Cancer Med; 2021 Apr; 10(7):2232-2241. PubMed ID: 33314708
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.
Angelini P; London WB; Cohn SL; Pearson AD; Matthay KK; Monclair T; Ambros PF; Shimada H; Leuschner I; Peuchmaur M; Irwin MS; Baruchel S
Eur J Cancer; 2012 May; 48(8):1185-91. PubMed ID: 22137163
[TBL] [Abstract][Full Text] [Related]
34. The late recurrence of ganglioneuroma 21 years after initial presentation with neuroblastoma.
Okita Y; Narita Y; Yoshida A; Miyakita Y; Ohno M; Saio M; Yoshimi N; Shibui S
Pediatr Hematol Oncol; 2012 Oct; 29(7):647-51. PubMed ID: 22966943
[TBL] [Abstract][Full Text] [Related]
35. [N-myc oncogene amplification in tumors of the sympathetic nervous system: preliminary study of methods and clinico-pathologic correlations].
Dahbiová R; Kodet R; Soukup J; Kavan P; Smelhaus V; Koutecký J
Cesk Patol; 1997 Aug; 33(3):83-8. PubMed ID: 9471397
[TBL] [Abstract][Full Text] [Related]
36. Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
Meany HJ; London WB; Ambros PF; Matthay KK; Monclair T; Simon T; Garaventa A; Berthold F; Nakagawara A; Cohn SL; Pearson AD; Park JR
Pediatr Blood Cancer; 2014 Nov; 61(11):1932-9. PubMed ID: 25044743
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of fluorodeoxyglucose positron emission tomography/computed tomography for detection of a neuroblastic nodule in a ganglioneuroblastoma: a case report.
Takeda Y; Sano H; Kawano A; Mochizuki K; Takahashi N; Kobayashi S; Ohara Y; Tasaki K; Hosoya M; Kikuta A
J Med Case Rep; 2018 May; 12(1):119. PubMed ID: 29720264
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of benign neuroblastic tumors: Is surgery always necessary?
Whitlock RS; Mehl SC; Larson SK; Foster JH; Hicks J; Nuchtern JG; Sher AC; Vasudevan SA; Naik-Mathuria B
J Pediatr Surg; 2022 Aug; 57(8):1538-1543. PubMed ID: 34281709
[TBL] [Abstract][Full Text] [Related]
39. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
40. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.
Fischer J; Pohl A; Volland R; Hero B; Dübbers M; Cernaianu G; Berthold F; von Schweinitz D; Simon T
BMC Cancer; 2017 Aug; 17(1):520. PubMed ID: 28778185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
